Michael N. Abrams

The biopharmaceutical industry contemplates product innovation within the changing landscape of healthcare.

A look back at the history of orphan drugs in the industry.

Rather than seeking a single indication for one large group, the orphan-drug approach segments the market for a drug more minutely.